[Determinants of bleeding risk in anticoagulated patients in primary care: A retrospective observational study]. [PDF]
Ciorba FR +2 more
europepmc +1 more source
[Case report: ablation of atrial fibrillation in patient with an interatrial septal oclussion device]. [PDF]
Montesinos-Segura R +6 more
europepmc +1 more source
[Educational program to improve knowledge and therapeutic range for self-controlled anticoagulated patients]. [PDF]
Romero-Arana A +5 more
europepmc +1 more source
[Increased risk of bleeding in patients with atrial fibrillation and chronic kidney disease on hemodialysis treated with anticoagulants. A four center serie]. [PDF]
López-Gutiérrez LV +8 more
europepmc +1 more source
[Selection of pharmacogenomic variants and methodology for their use in community pharmacy]. [PDF]
Montero-Gómez A, Sánchez Pozo A.
europepmc +1 more source
Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis. [PDF]
Li Z +6 more
europepmc +1 more source
Ischemic cerebrovascular accident in an HIV patient: Neurosyphilis and antiphospholipid syndrome [PDF]
Ayala S, Ortiz MDM, Vásquez MC.
europepmc +1 more source
[COVID-19 vaccine and anticoagulation patients at high cardiovascular risk. SEMERGEN recommendations]. [PDF]
Pallarés-Carratalá V +6 more
europepmc +1 more source
Dabigatrán fronte acenocumarol ou warfarina en pacientes con fibrilación auricular
[Abstract] Introduction: Non-valvular atrial fibrillation is the most frequent arrhythmia and stroke is his principal complication. In patients at high risk of embolization, anticoagulant therapy proved to be highly effective. Antagonists of vitamin K (AVK) [acenocoumarol (Sintrom®) and warfarin (Aldocumar®) were for decades the only option available ...
García Costa, Noelia +1 more
openaire +1 more source

